$RELX

Why is Relx stock climbing today? By Investing.com

Relx shares rose about 2% in pre-open trading after the company reported H1 2026 interim results. According to Relx, underlying revenue grew 7% to £4,871m and adjusted operating profit rose 9% to £1,727m. Adjusted EPS increased 11% at constant currency, with Legal leading. Relx reaffirmed full-year outlook and said AI-enabled tools supported growth.

Original reporting
Published Jul 23, 2026, 9:24 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 9:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RELX
Bullish
medium confidence
Mentioned
$RELX
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$RELXBullishMed
01

Why it matters

H1 results show broad-based growth, Legal segment acceleration, and margin expansion, which the article presents as direct evidence against AI disruption fears, alongside a reaffirmed full-year outlook.

02

Market read

Provides concrete H1 financial datapoints and segment drivers that explain a same-day pre-open bid for RELX.

03

What to watch

The article does not quantify guidance ranges or discuss competitive intensity in AI legal tools, leaving uncertainty around sustainability of the Legal outperformance.

Relevance 7/10Novelty 7/10Timing: pre-open trading reaction to H1 2026 interim results

Background

Relx’s Legal franchise has been under investor scrutiny due to fears that third-party AI legal tools could erode its advantage.

Company-level read

Ticker impact

$RELXBullishMedium confidence
Context

Relx shares rose 2% pre-open after H1 2026 interim results showed 7% underlying revenue growth and 9% adjusted operating profit growth.

Expected impact

Near-term upside bias likely persists while investors digest the reaffirmed full-year outlook and margin expansion.

Evidence & confidence

The text provides specific H1 financial metrics, Legal segment growth, margin expansion, and a management reaffirmation, which are actionable for positioning.

Market effects

Supports the narrative that legal/analytics incumbents can defend margins and share against AI-enabled disruption.

Limited, as the catalyst is company-specific and the article notes broader US indices are slightly lower.

Moderate, given Relx’s international footprint and the cross-border relevance of AI-enabled legal tooling adoption.

Counterpoint

The stock move may fade if investors view the AI-disruption concern as only partially resolved, or if full-year growth assumptions prove too optimistic.

Key entities

  • Relx

    London-headquartered information analytics group reporting H1 2026 interim results and reaffirming full-year outlook.

  • Lexis+

    AI-enabled legal tools cited as driving Legal segment growth.

  • Protege workflow platform

    Workflow platform cited as contributing to Legal segment performance.

  • Anthropic

    Third-party AI provider whose legal AI tool is referenced as a source of prior investor disruption fears.

Related articles

$RELXMed

Relx H1 Earnings Call Highlights

RELX (RELX) reported H1 earnings call highlights, citing growth across Risk, STM, Legal, and Exhibitions. Risk and Insurance benefited from financial crime compliance and digital fraud solutions. STM revenue rose 6% and underlying adjusted operating profit 8%. Legal posted 10% underlying revenue growth and 13% profit growth, driven by Lexis+ with Protégé. Management reiterated full-year growth expectations and said AI token costs are under 1% of costs.

$RELXMed

RELX rises as AI helps with new products and costs

RELX PLC shares rose 1.5% to 2,491p after the FTSE 100 group reported higher first-half revenue and profit. Underlying revenue grew 7% and adjusted operating profit rose 9% to £1.7 billion, with margins improving to 35.5%. The board lifted the interim dividend 7% to 20.9p and said it expects strong full-year growth.

$BPMedAI 8/10

FTSE 100 up despite Asia-focused financials falls

The FTSE 100 rose 0.3% to 10,360.32 as oil weakness weighed on majors less than expected; Brent fell to $94.88/bbl. Asia-focused banks and insurers dropped after a report said mainland residents face tighter limits opening offshore accounts in Hong Kong. Prudential fell 7.2%, HSBC 2.2%, Standard Chartered 3.2%. Broadcom sank 14% despite record results.

$RELXMedAI 9/10

Broker says CMA ruling on Google shifts power balance towards UK publishers

Panmure Liberum said the UK Competition and Markets Authority’s 3 June ruling requiring Google to follow conduct rules on publisher content for AI search shifts leverage toward UK publishers. The broker cited three elements: publisher opt-out controls (including training/grounding), Google reporting usage metrics, and accurate attribution. It expects near-term benefits for Reach PLC (buy, 139p) and Future (buy, 500p), while noting implementation/enforcement criticisms. Panmure also flagged publi